Clinical Trial Update: Abdominal Obesity, Cardiovascular Inflammation, and Effects of Growth Hormone Releasing Hormone Analogue [NA]

View source ↗

Summary

A clinical trial evaluating abdominal obesity, cardiovascular inflammation, and the effects of a Growth Hormone Releasing Hormone Analogue has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Obesity

Drugs mentioned

• Growth Hormone Releasing Hormone Analogue

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Abdominal Obesity | NA | Status: WITHDRAWN